Skip to content

A Clinical Study on the Assessment of Fallopian Tube Patency after Conservative Treatment with Traditional Chinese Medicine for Ectopic Pregnancy Using Multimodal Ultrasound Contrast Imaging

A Clinical Study on the Assessment of Fallopian Tube Patency after Conservative Treatment with Traditional Chinese Medicine for Ectopic Pregnancy Using Multimodal Ultrasound Contrast Imaging

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2026000494
Enrollment
Unknown
Registered
2026-03-10
Start date
2025-12-30
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ectopic Pregnancy

Interventions

The patient was hospitalized in the gynecology department of Guangzhou University of Traditional Chinese Medicine Affiliated First Hospital for tubal pregnancy and underwent treatment with Chinese her
Hospitalized in the Gynecology Department of Guangzhou University of Traditional Chinese Medicine Affiliated First Hospital for combined traditional Chinese and Western medicine treatment (Chinese her
During the same period, patients recruited from the outpatient clinic who had a history of conservative treatment with Western medicine alone for ectopic pregnancy within the past six months (Western

Sponsors

Guangzhou University of Traditional Chinese Medicine First Affiliated Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1) Age between 18 and 45 years old, with a history of ectopic pregnancy treated solely with medical conservative therapy, where serum ß-HCG has returned to normal and ultrasound has confirmed the disappearance of the mass for three months; 2) Having fertility needs and willing to undergo hysterosalpingography (HSG); 3) Normal leukorrhea examination, coagulation function, and infection-related tests; 4) Voluntarily signed the informed consent form and approved by the ethics committee.

Exclusion criteria

Exclusion criteria: 1) Patients with acute and subacute inflammation of pelvic reproductive organs; 2) Patients with severe organic diseases of the brain, heart, liver, kidneys, etc., blood disorders, endocrine system diseases, immunodeficiency, or malignant tumors; 3) Patients with poor compliance, incomplete clinical data, lack of follow-up conditions, or mental disorders; 4) Patients with a history of allergy to sulfur hexafluoride microbubbles used in ultrasound contrast agents; 5) Patients who required surgical intervention for tubal pregnancy rupture during drug therapy or who previously requested conversion to surgical treatment.

Design outcomes

Primary

MeasureTime frame
Fallopian tube patency;

Countries

China

Contacts

Public ContactLiang Shiying

Guangzhou University of Traditional Chinese Medicine First Affiliated Hospital

176509822@qq.com+8615920195635

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Apr 4, 2026